Oxford BioMedica PLC (OXBDF)
4.401
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Oxford BioMedica Enterprise Value: 361.90M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | 361.90M |
May 30, 2024 | 361.90M |
May 29, 2024 | 361.90M |
May 28, 2024 | 361.90M |
May 24, 2024 | 361.90M |
May 23, 2024 | 361.90M |
May 22, 2024 | 361.84M |
May 21, 2024 | 361.84M |
May 20, 2024 | 307.84M |
May 17, 2024 | 307.84M |
May 16, 2024 | 307.84M |
May 15, 2024 | 307.84M |
May 14, 2024 | 307.84M |
May 13, 2024 | 307.84M |
May 10, 2024 | 307.84M |
May 09, 2024 | 307.84M |
May 08, 2024 | 307.84M |
May 07, 2024 | 307.84M |
May 06, 2024 | 300.84M |
May 03, 2024 | 300.84M |
May 02, 2024 | 300.84M |
May 01, 2024 | 212.84M |
April 30, 2024 | 212.84M |
April 29, 2024 | 212.84M |
April 26, 2024 | 212.84M |
Date | Value |
---|---|
April 25, 2024 | 203.84M |
April 24, 2024 | 193.84M |
April 23, 2024 | 193.84M |
April 22, 2024 | 183.84M |
April 19, 2024 | 183.34M |
April 18, 2024 | 183.34M |
April 17, 2024 | 183.34M |
April 16, 2024 | 183.34M |
April 15, 2024 | 183.34M |
April 12, 2024 | 183.34M |
April 11, 2024 | 183.34M |
April 10, 2024 | 184.34M |
April 09, 2024 | 184.34M |
April 08, 2024 | 184.34M |
April 05, 2024 | 184.34M |
April 04, 2024 | 165.84M |
April 03, 2024 | 165.84M |
April 02, 2024 | 164.84M |
April 01, 2024 | 164.84M |
March 28, 2024 | 164.74M |
March 27, 2024 | 164.74M |
March 26, 2024 | 164.74M |
March 25, 2024 | 169.74M |
March 22, 2024 | 167.74M |
March 21, 2024 | 167.74M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
129.08M
Minimum
Dec 04 2023
1.804B
Maximum
Sep 23 2021
683.98M
Average
569.08M
Median
Mar 04 2020
Enterprise Value Benchmarks
Adaptimmune Therapeutics PLC | 142.58M |
Biodexa Pharmaceuticals Plc | 1.860M |
Verona Pharma PLC | 772.32M |
NuCana PLC | -8.064M |
Autolus Therapeutics PLC | 356.16M |
Enterprise Value Related Metrics
Earnings Yield | -46.14% |
Normalized Earnings Yield | -18.15 |